Table 1.
Demographic characteristics of chronic HCV patients and non-HCV patients
| Chronic HCV patients (n = 128,967) |
Non-HCV patients (n = 515,868) |
|||
|---|---|---|---|---|
| n | (%) | n | (%) | |
| Male | 65,781 | (51.0) | 263,124 | (51.0) |
| Age (years), median (range) | 70 | (18–107) | 70 | (18–109) |
| Age category (years) | ||||
| 18–24 | 556 | (0.4) | 2224 | (0.4) |
| 25–29 | 779 | (0.6) | 3116 | (0.6) |
| 30–34 | 1388 | (1.1) | 5552 | (1.1) |
| 35–39 | 2095 | (1.6) | 8380 | (1.6) |
| 40–44 | 3252 | (2.5) | 13,008 | (2.5) |
| 45–49 | 4639 | (3.6) | 18,556 | (3.6) |
| 50–54 | 7008 | (5.4) | 28,032 | (5.4) |
| 55–59 | 9221 | (7.1) | 36,884 | (7.1) |
| 60–64 | 13,581 | (10.5) | 54,324 | (10.5) |
| 65–69 | 19,222 | (14.9) | 76,888 | (14.9) |
| 70–74 | 20,376 | (15.8) | 81,504 | (15.8) |
| 75–79 | 20,279 | (15.7) | 81,116 | (15.7) |
| 80–84 | 16,881 | (13.1) | 67,524 | (13.1) |
| 85–89 | 7525 | (5.8) | 30,100 | (5.8) |
| ≥ 90 | 2165 | (1.7) | 8660 | (1.7) |
| Chronic HCV diseasea | ||||
| Chronic hepatitis C | 85,282 | (66.1) | – | |
| Hepatitis C | 42,802 | (33.2) | – | |
| HCV-related cirrhosis | 11,533 | (8.9) | – | |
| Hepatitis C virus infection | 2560 | (2.0) | – | |
| Decompensated HCV-related cirrhosis | 645 | (0.5) | – | |
| Compensated HCV-related cirrhosis | 434 | (0.3) | – | |
| With treatment of HCV | 17,244 | (13.4) | – | |
| DAA | 16,338 | (94.7) | – | |
| Peginterferon + ribavirin | 906 | (5.3) | – | |
| Mental and behavioural disorders due tob | ||||
| Alcohol | 515 | (0.4) | 1114 | (0.2) |
| Tobacco | 345 | (0.3) | 607 | (0.1) |
| Psychoactive substance use | 137 | (0.1) | 135 | (0.0) |
| Opioid use | 0 | (0.0) | 0 | (0.0) |
| Co-infectionb | ||||
| HIV | 336 | (0.3) | 167 | (0.0) |
| HBV | 5368 | (4.2) | 4823 | (0.9) |
| Hospital admissionc | 55,423 | (43.0) | 141,817 | (27.5) |
| Total length of hospital admissions (days), median (range) | 18 | (1–678) | 13 | (1–684) |
| Total number of hospital admissions | ||||
| Once | 32,492 | (25.2) | 100,483 | (19.5) |
| Twice or more | 22,931 | (17.8) | 41,334 | (8.0) |
Notes: HCV, hepatitis C virus; DAA, direct-acting antiviral agent; HBV, hepatitis B virus
aFor diseases coded as chronic HCV (B18.2), the number and proportion of patients with that specific disease were shown
bFor the following diseases, the number and proportion of patients with at least one disease record during the study period were shown: mental and behavioural disorders due to use of alcohol (F10); tobacco (F17); psychoactive substances (F12–16, F18–19); opioids (F11), HIV (B20–24), and HBV (B18.0, B18.1)
cAll-cause hospital admissions during the study period were counted